We recently showed that subcutaneous implantation of localized B16 melanoma engineered to overexpress ST6Gal-1 could partially alleviate neutrophilic airway inflammation when challenged intratracheally with LPS in mice (1). Here, ST6GAL1 is linked to melanoma.